Sign in →

Test Code SFGP Spotted Fever Group Antibody, IgG and IgM, Serum

Reporting Name

Spotted Fever Group Ab, IgG, IgM, S

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum


Specimen Required


Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into plastic vial.


Specimen Minimum Volume

0.2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
  Frozen  14 days

Reference Values

IgG: <1:64

IgM: <1:64

Reference values apply to all ages.

Day(s) Performed

Monday through Friday

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86757 x 2

LOINC Code Information

Test ID Test Order Name Order LOINC Value
SFGP Spotted Fever Group Ab, IgG, IgM, S 90260-1

 

Result ID Test Result Name Result LOINC Value
84342 Spotted Fever Group Ab, IgG, S In Process
84346 Spotted Fever Group Ab, IgM, S In Process

Testing Algorithm

For more information see Acute Tick-Borne Disease Testing Algorithm.

Useful For

Aiding in the diagnosis of spotted fever group rickettsial infections

Interpretation

This test detects reactivity to the group-specific rickettsia. For example, antibody reactivity to the Rickettsia rickettsii will also react with other organisms within the spotted fever group.

 

IgG

Titer results of 1:256 and above:

-Serum end point titers of 1:256 and above are considered presumptive evidence of recent or current infection by organisms of appropriate rickettsial antigen group.

 

Titer results from 1:64 to 1:256:

-Single serum end point titers from 1:64 to 1:256 are suggestive of infection at an undetermined time and may indicate either past infection or early response to a recent rickettsial infection.

-A 4-fold or greater increase in IgG titer between 2 serum specimens collected 1 to 2 weeks apart and tested in parallel is considered presumptive evidence of a recent or current infection.

-In patients infected with organisms within the rickettsial groups, IgG antibody is generally detectable within 1 to 2 weeks of onset of symptoms, peaking within 1 to 2 months and declining thereafter. Following prompt antimicrobial treatment, titers generally decline below detectable levels within 8 to 11 months. With relapse, prior immunization, or delayed antibiotic treatment, IgG levels may remain elevated for more than a year post-onset.

 

IgM

Titer results of 1:64 and above:

-Titers of 1:64 and above are considered presumptive evidence of recent or current infection by organisms of appropriate rickettsial antigen group.

 

Titer results below 1:64:

-Titers below 1:64 suggest that the patient does not have an acute rickettsial infection.

-IgM class antibody is transiently detected within 1 to 2 weeks of onset of symptoms, usually declining rapidly within 3 months following prompt antibiotic treatment. These levels will also be elevated for an extended period with relapse, prior immunization, or delayed antibiotic treatment.

Clinical Reference

1. Walker DH, Bouyer DH: Rickettsia: In: Murray PR, Baron EJ, Jorgenson JH, et al, eds. Manual of Clinical Microbiology. 8th ed. ASM Press; 2003:1005-1014

2. Helmick C, Bernard K, D'Angelo L: Rocky Mountain spotted fever. Clinical laboratory and epidemiological features of 262 cases. J Infect Dis. 1984 Oct;150(4):480-488

3. Centers for Disease Control and Prevention: Tickborne diseases of the United States. A Reference Manual for HealthCare Providers. 6th ed. 2022. Accessed September 21, 2022. Available at www.cdc.gov/ticks/tickbornediseases/TickborneDiseases-P.pdf

Report Available

Same day/1 to 3 days

Method Name

Immunofluorescence

Forms

If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.